{
    "Trade/Device Name(s)": [
        "ABL90 Flex",
        "ABL90 Flex Analyzer"
    ],
    "Submitter Information": "Radiometer Medical ApS",
    "510(k) Number": "K122642",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092686",
        "K111897",
        "K120197",
        "K092682"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CHL",
        "CEM",
        "JGS",
        "JFP",
        "CGZ",
        "CGA",
        "KHP",
        "GKR",
        "GHS",
        "KQI",
        "JJY",
        "JIX"
    ],
    "Summary Letter Date": "October 1, 2012",
    "Summary Letter Received Date": "October 3, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1120"
    ],
    "Regulation Name(s)": [
        "Blood gases and blood pH test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "pH",
        "pO2",
        "pCO2",
        "Potassium",
        "Sodium",
        "Calcium",
        "Chloride",
        "Glucose",
        "Lactate",
        "Total hemoglobin",
        "Oxygen saturation (sO2)",
        "Oxyhemoglobin (FO2Hb)",
        "Carboxyhemoglobin (FCOHb)",
        "Methemoglobin (FMetHb)",
        "Reduced hemoglobin (FHHb)",
        "Fetal hemoglobin (FHbF)"
    ],
    "Specimen Type(s)": [
        "Heparinised whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ABL90 Flex Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Potentiometry",
        "Amperometry",
        "Spectrophotometry",
        "Wireless LAN network connectivity",
        "Aspiration sample introduction",
        "Menu driven touch screen",
        "Liquid calibration"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "Automated system",
        "Point-of-care"
    ],
    "Document Summary": "FDA 510(k) summary for the Radiometer Medical ABL90 Flex Analyzer, a portable automated system for measuring blood gases, electrolytes, metabolites, and hemoglobin fractions in whole blood.",
    "Indications for Use Summary": "For in vitro measurement of pH, blood gases, electrolytes, glucose, lactate, and oximetry in heparinised whole blood, aiding diagnosis and treatment of various acid-base, electrolyte, metabolic, and hemoglobin-related disorders, for use in laboratory, near-patient, or point-of-care settings by trained healthcare professionals under physician order.",
    "fda_folder": "Clinical Chemistry"
}